A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer
Clinical trial NCT01399684 · COMPLETED
Trial details
- NCT number
- NCT01399684
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.